en

PRODUCT DETAIL

Spiromon 5 mg žuvacie tablety

Code 20353
MA number 14/0347/10-S
Product Form: tbl mnd 56x5 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC Leukotriene receptor antagonists
R03DC03 Montelukast
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.06.2010
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Spiromon 5 mg_tbl mnd_03/2024.pdf  
SPC: SPC_Spiromon 5 mg_tbl mnd_03/2024.pdf  
Safety feature Yes
Data update: 05.06.2018
eu-flag.png sk-flag.png